Clinical Trial Update: Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide as maintenance therapy after tandem autologous and allogeneic transplant in newly diagnosed multiple myeloma; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED